Stevanato Group SpA (STVN NYSE) stock market data APIs
$20.2192
0.44(2.2%)
as of March 13, 2025
Stevanato Group SpA Financial Data Overview
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
Prev. Close
19.7812
Open
20.2192
High
19.982
Low
19.3609
52 wk Range
16.56-33.394
Market Cap
5 412 M
P/E Ratio
42.1915
Shares Outstanding
49 605 K
Revenue
1 104 M
EPS
0.2047
Dividends (Yield)
0.0029
Beta
0.598
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Stevanato Group SpA data using free add-ons & libraries
Get Stevanato Group SpA Fundamental Data
Stevanato Group SpA Fundamental data includes:
- Net Revenue: 1 104 M
- EBITDA: 237 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2024-12-31
- EPS/Forecast: 0.1939
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Stevanato Group SpA News
New
Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum
PIOMBINO DESE, Italy, March 11, 2025--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical...
Stevanato Group Full Year 2024 Earnings: In Line With Expectations
Stevanato Group (NYSE:STVN) Full Year 2024 Results Key Financial Results Revenue: €1.10b (up 1.7% from FY 2023). Net income: €117.8m (down 19% from FY 2023). Profit margin: 11% (down from 13% in...
Stevanato Group SpA (STVN) Q4 2024 Earnings Call Highlights: Navigating Growth Amidst Challenges
Revenue Growth: 2% increase for fiscal year 2024, driven by 6% growth in Biopharmaceutical and Diagnostic Solutions segment. Fourth Quarter Revenue: EUR330.6 million, a 3% increase year-over-year. Hig...
Q4 2024 Stevanato Group SpA Earnings Call
Participants Lisa Miles; Senior Vice President, Investor Relations; Stevanato Group SpA Franco Stevanato; Executive Chairman of the Board; Stevanato Group SpA Marco Dal Lago; Chief Financial Office...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
